Cytokine and growth factor involvement in schizophrenia—support for the developmental model
- 1 November 2000
- journal article
- review article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 5 (6) , 594-603
- https://doi.org/10.1038/sj.mp.4000730
Abstract
Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatmentKeywords
This publication has 135 references indexed in Scilit:
- Neurotrophins and Basic Fibroblast Growth Factor Induce the Differentiation of Calbindin-Containing Neurons in the Cerebral CortexExperimental Neurology, 1997
- No difference in the expression of the D4 gene in post-mortem frontal cortex from controls and schizophrenicsNeuroscience Letters, 1996
- The relative abundance of dopamine D4 receptor mRNA in post mortem brains of schizophrenics and controlsSchizophrenia Research, 1996
- Brain-derived neurotrophic factor works coordinately with partner molecules to initiate tyrosine hydroxylase expression in striatal neuronsBrain Research, 1995
- Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusersBrain Research, 1995
- Excitatory amino acids: Implications for psychiatric disorders researchLife Sciences, 1994
- Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenicsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- Schizophrenia: the cellular biology of a functional psychosisTrends in Neurosciences, 1990
- [3H]Muscimol binding sites increased in autopsied brains of chronic schizophrenicsLife Sciences, 1987
- Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophreniaLife Sciences, 1983